文献速递前列腺癌

前列腺癌患者的抑郁、焦虑与自杀倾向:观察性研究的系统综述与荟萃分析

Depression, anxiety, and suicidality in patients with prostate cancer: a systematic review and meta-analysis of observational studies.
PubMed 文献 · Prostate Cancer Prostatic Dis · 2020-09-25

该系统综述纳入117项观察性研究,评估前列腺癌患者抑郁、焦虑及自杀倾向的患病率与自杀死亡率。抑郁障碍汇总患病率5.81%,显著抑郁症状17.07%,显著焦虑症状16.86%,近期自杀意念9.85%,诊断后粗自杀死亡率为47.1/10万人年。提示前列腺癌患者精神健康负担显著,应加强筛查与身心整合照护。

要点

  • 前列腺癌患者抑郁障碍汇总患病率为5.81%。
  • 显著抑郁症状和焦虑症状分别占17.07%和16.86%。
  • 近期自杀意念9.85%,自杀死亡率47.1/10万人年。

核心结论

  • 前列腺癌患者抑郁、焦虑和自杀症状常见,自杀死亡率较高。

研究设计与样本

  • 系统综述与荟萃分析,检索MEDLINE、Scopus、PsycInfo和Cochrane Library至2020年5月26日,最终纳入117项观察性研究。

主要发现

  • 抑郁障碍汇总患病率5.81%(95%CI 4.36-7.46),基于11项研究、655,149例患者。
  • 显著抑郁症状汇总患病率17.07%(95%CI 15.14-19.09),基于76项研究、32,339例患者。
  • 显著焦虑症状汇总患病率16.86%(95%CI 14.92-18.89),基于56项研究、24,526例患者。
  • 近期自杀意念汇总患病率9.85%(95%CI 7.31-12.70),基于8项研究、6,173例患者。
  • 诊断后粗自杀死亡率为47.1/10万人年(95%CI 39.85-54.96),基于12项研究。

临床怎么用

  • 应评估对前列腺癌患者进行抑郁、焦虑和自杀风险筛查,并探索身心整合照护模式。

局限性

  • 存在显著异质性,敏感性分析提示异质性来源可能包括诊断方法、研究规模和地点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Psychiatric implications of prostate cancer are increasingly recognised, having important effects on oncological and functional outcomes. However, findings for co-occurring depression, anxiety, and suicidality remain variable. Therefore, this review of observational studies aimed to establish best estimates of the prevalence and rates of these outcomes in prostate cancer patients. METHODS: A systematic literature search was conducted using MEDLINE, Scopus, PsycInfo, and Cochrane Library databases from inception up to 26 May 2020. Observational studies using validated methods for evaluating prevalences of depression, anxiety and suicidal ideation, or suicide mortality rates post prostate cancer diagnosis were included. Random effect models were used to calculate pooled prevalences of depressive and anxiety symptoms or disorders, and suicidal ideation post diagnosis. Additionally, pooled crude suicide mortality rates per 100,000 person years were calculated. Heterogeneity was explored using a stratified analysis. RESULTS: Of 3537 articles screened, 117 were included. Pooled prevalence for depressive disorders was 5.81% (95% CI 4.36-7.46) in 11 studies, representing 655,149 patients. Significant depressive symptoms were identified in 17.07% (15.14-19.09) across 32,339 patients and 76 studies. In total, 16.86% (14.92-18.89) had significant anxiety symptoms in 56 studies combining 24,526 patients. In 6,173 patients and eight studies, recent suicidal ideation was present in 9.85% (7.31-12.70). Crude suicide mortality rate after diagnosis was 47.1 (39.85-54.96) per 100,000 person years in 12 studies. Significant heterogeneity was seen with potential sources identified through our sensitivity analysis including diagnostic method utilised, study size and location of study. CONCLUSIONS: The mental health impact in patients with prostate cancer is significant. Depressive, anxiety, and suicidal symptoms were common. Additionally, a high suicide mortality rate was identified when compared to general population estimates. Screening of patients and integration of physical and mental health care should be evaluated further to improve quality of life and functional outcomes.

来源:Prostate Cancer Prostatic Dis,查看原文。版权归原作者所有。

引用

  1. Brunckhorst O, Hashemi S, Martin A, et al. Depression, anxiety, and suicidality in patients with prostate cancer: a systematic review and meta-analysis of observational studies. Prostate Cancer Prostatic Dis. 2020. PMID: 32978524. doi:10.1038/s41391-020-00286-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。